NueCura Partners announced today the finalization of its third investment in Nashville-based healthcare startup EvidenceCare.
With $468,367 being invested this tranche, this investment brings NueCuras total cash investment to $959,000, making the group EvidenceCares largest preferred shareholder and cash investor to date.
EvidenceCare, a clinical decision support tool for healthcare providers, was conceived in 2014 to solve a fundamental need for healthcare providers to find and quickly digest the latest treatment guidelines.
Having NueCura in our corner has allowed us to mature in ways we couldnt have on our own, said EvidenceCares CEO and founder, Dr. Brian Fengler. They have not only propelled us with the necessary funds to launch and grow our business, but they have also given us critical thought leadership that has helped shape our vision. This current investment is further endorsement that they truly believe in what we are accomplishing at EvidenceCare.
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
In 2016, the company launched its technology and currently has a variety of protocols for emergency medicine, antibiotic stewardship, gastroenterology and more, with content accredited by the American College of Emergency Physicians and the American College of Gastroenterology for CME credit. In addition, the platform integrates a patient education tool that enhances the dialogue providers have with their patients and a feature that accelerates documentation into any EHR.
We want to be involved with EvidenceCare long-term, said Dr. Don Lazas, founder and managing partner at NueCura. Theyre changing healthcare with their tool, and we are thrilled to be a part of it.
Nashville-based EvidenceCare is a clinical decision support publishing platform designed by emergency physician Dr. Brian Fengler. Unlike any tool on the market, EvidenceCare provides clinicians with access to patient-specific, evidence-based treatment recommendations at the bedside in as little as 30 seconds. Since its launch in July 2016, the companys proprietary content publishing platform is delivering protocols authored by industry-leading experts to healthcare clinicians worldwide. To learn more visit www.evidence.care.
About NueCura Partners, LLC
NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies and services in the healthcare space. www.nuecura.com